Cover Image
市場調查報告書

中國的醫院產業的發展與投資分析

China Hospital Development and Investment Report, 2014-2017

出版商 ResearchInChina 商品編碼 310896
出版日期 內容資訊 英文 157 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的醫院產業的發展與投資分析 China Hospital Development and Investment Report, 2014-2017
出版日期: 2014年08月12日 內容資訊: 英文 157 Pages
簡介

在旺盛的需求及醫療制度改革推動下,中國醫院產業在近年急速成長。中國的醫院數年平均增加率(CAGR)在2011∼2013年達到6%,比2005∼2010年的數值高了2.26%。此外,醫院產業收益額在2011∼2013年則以年平均(CAGR)23.6%的速度擴大。一般預測今後也將維持年度20%以上的成長率,到2017年將達到4兆700億人民幣的規模。與此同時,醫院市場則朝向新企業加入及企業合併、收購(M&A)、官民合作方向發展,2013年末醫院數有45.8%由私立醫院所佔。在收益結構方面,公營醫院雖然確保了90%的佔有率,但目前卻有滑落的趨勢。民間投資的投資額則集中於小額但收益率高,需要也龐大的專科醫院,私立醫院約65%成為專科醫院。專科醫院(牙科、整形外科及美容外科等)利益率高達10%以上,並達到遠遠超越醫院產業整體(約5%)的利益率。他們以高所得階級為對象,以外資型醫院或合併企業等型式,打入沿海的各大都市。

本報告提供中國的醫院產業(特別是私立醫院·外資醫院)相關分析,提供您市場整體結構最新趨勢,專門醫院領域的詳細趨勢,醫療保險的整頓現狀,都市化的影響,投資的投下情形,公立/私立醫院的業績比較,外資醫院趨勢調查,以及主要企業·醫院簡介等。

第1章 中國的醫院產業概要

  • 定義
  • 分類
  • 相關產業

第2章 中國的醫院市場概要

  • 醫院數
    • 醫院數的穩定性成長
    • 私立醫院成長更加快速
    • 醫院數的地區間差距
  • 收益額
    • 收益總額的急速擴大
    • 綜合醫院的收益額佔有率龐大
    • 醫藥品佔綜合醫院的收益額佔有率低
  • 利益
    • 報酬率的復甦
    • 專門醫院的毛利率達到最高水準
  • 醫療服務
    • 醫療資源的分佈極度不平衡
    • 未充分受到醫療資源的人民存在,影響醫院產業的成長
  • 競爭模式

第3章 中國國內專門醫院的最新趨勢

  • 營運情形
    • 民間專門醫院的比率持續上升
    • 專門醫院的收益額急速擴大
    • 專門醫院的報酬率:和其他大幅不同
  • 各種的專門醫院現況
    • 眼科醫院
    • 牙科醫院
    • 整形外科·美容外科醫院
    • 婦產科醫院
    • 小兒科醫院
    • 癌症醫院

第4章 中國的醫院產業的發展預測

  • 中國的醫療保險現況
    • 醫療保險制度
    • 醫療保險的覆蓋率不久將達到100%
    • 都市區/農村的重病患者醫療保險
  • 伴隨都市化促進醫院產業發展
    • 中國的都市化現況
    • 都市化的醫療保險制度最佳化
    • 地區橫斷型的醫療保險付款制度順利普及
    • 都市化的發展度,仰賴於醫療保險制度的保險費
    • 醫療保險基金的收支更加惡化
    • 縣層級醫院的醫療資源供給情形改善預測
    • 透過中央政府,強化都市區的醫療資源的投資

第5章 中國的醫院產業的投資

  • 投資環境的好轉
  • 公立醫院和私立醫院的比較
    • 公立醫院的獨佔地位
    • 私立醫院的高營運效率
  • 社會資本的投資機會
    • 專門醫療領域
    • 公立綜合醫院
  • 外資醫院的發展的方向性與營運形態
    • 中國的外資醫院現況
    • 外資醫院的發展的方向性
    • 外資醫院的營運形態

第6章 主要企業

  • Aier Eye Hospital Group
    • 簡介
    • 經營概況
    • 收益結構
    • 毛利率
    • 醫療服務
    • 未來預測
  • TC Medical
  • Mayinglong Pharm
  • Shanghai Fosun Pharmaceutical
  • Jinling Pharmaceutical
  • Shinva Medical
  • Xi'an Kaiyuan Investment
  • Inner Mongolia Furui Medical Science
  • Wuhan Jianmin Pharmaceutical
  • CMS Holdings Ltd.
  • United Family Hospital
  • Parkway Pantai
  • Phoenix Healthcare
  • Yibai Pharmaceutical
  • China Resources Sanjiu
  • Kangmei Pharmaceutical
  • Jiangnan Mould & Plastic Technology

第7章 摘要與預測

  • 摘要
  • 未來預測

圖表一覽

目錄
Product Code: PQ011

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6% in 2011-2013, higher than 2.26% in 2005-2010. The revenue of China hospital industry jumped at a CAGR of 23.6% in 2011-2013, and it is expected to maintain the growth rate of over 20% and hit RMB4.07 trillion in 2017.

At the same time, various social capital flows to the Chinese hospital market by self-establishment, mergers and acquisitions (including participation in the restructuring of public hospitals), joint ventures, associates and other forms, which boosts the expansion of private hospitals. As of the end of 2013, Chinese private hospitals had accounted for 45.8% of the total Chinese hospitals, increasing by 24.5 percentage points compared with 2006. However, from the point of view of revenue structure, public hospitals still took a dominant position with the proportion of over 90%, but the figure shows a decreasing trend now.

In the private hospital investment boom, specialized hospitals involved with small investment, high returns and strong market demand have become a hotspot for social capital. Currently, the proportion of Chinese specialized hospitals in private hospitals reaches about 65%. Specialized hospitals in huge demand, such as dental hospitals, ophthalmic hospitals, plastic surgery & cosmetic hospitals, even achieve the profit margins of more than 10%, much higher than the overall level of Chinese hospitals (about 5%).

The enterprises focusing on medicine, including Shanghai Fosun Pharmaceutical, Jinling Pharmaceutical, Inner Mongolia Furui Medical Science, Wuhan Jianmin Pharmaceutical, Yibai Pharmaceutical, China Resources Sanjiu and Kangmei Pharmaceutical, are actively extending to downstream medical services. Shanghai Fosun Pharmaceutical has stepped in obstetrics & gynecology, tumor and other areas through mergers and acquisitions; its revenue from hospital medical services reached RMB474.6 million in 2013, representing a substantial increase of 215.6% over previous year.

Targeting medium and high-end medical markets, foreign-funded enterprises mainly adopt cooperative operation, equity participation, joint ventures (under the lead of foreign investors) and other approaches to develop business in China, such as Chindex United Family Hospital and Parkway Pantai. United Family Hospital had covered Beijing, Shanghai, Wuxi, Guangzhou and Tianjin by the end of June 2014, and its hospitals in Qingdao and Guangzhou are under construction.

Revenue from Medical Services of China Hospitals by Company, 2011-2014

                     China Hospital Development and Investment Report, 2014-2017; ResearchInChina.

The report highlights the followings:

  • China hospital industry market overview: number of hospitals of all sorts, operation, status quo of medical service, competition pattern, etc.?
  • Current development of specialized hospitals in China: overall operation, operation of ophthalmic hospitals, dental hospitals, plastic surgery hospitals, cosmetic hospitals, obstetrics and gynecology hospitals, Children's hospitals, and tumor hospitals as well as their development outlook;
  • Development prediction of China hospital industry: status quo of China medical security, influence of urbanization enhancement on China healthcare market, supply and demand of medical resources;
  • Investment in China hospital industry: related polices on social capital flowing into the hospital industry, operational efficiency comparison between Private hospitals and public ones, investment opportunities of specialized hospitals and public hospitals, business mode of? foreign-funded hospitals in China;
  • Operation, investment, mergers & acquisitions, medical services and development prediction of 17 companies involved in the Chinese hospital market.

Table of Contents

1. Overview of China Hospital Industry

  • 1.1. Definition
  • 1.2. Classification
  • 1.3. Industry Chain

2. Overview of China Hospital Market

  • 2.1. Number of Hospitals
    • 2.1.1. Number of Hospitals Grows Steadily
    • 2.1.2. Private Hospitals Show Faster Growth Rate
    • 2.1.3. Distinct Regional Distribution of Hospitals
  • 2.2. Revenue
    • 2.2.1. Total Revenue Surges Rapidly
    • 2.2.2. Revenue of General Hospitals Occupies Lion's Share
    • 2.2.3. Proportion of Revenue from Medicine of General Hospitals on a Slow Decline
  • 2.3. Profit
    • 2.3.1. Profit Margin Recovers
    • 2.3.2. Gross Margin of Specialized Hospitals Records the Highest
  • 2.4. Medical Service
    • 2.4.1. Severely Uneven Distribution of Medical Resources
    • 2.4.2. Insufficient Medical Personal Impacts the Growth of Hospital Industry
  • 2.5. Competition Pattern

3. Current Development of Specialized Hospitals in China

  • 3.1. Operation
    • 3.1.1. Proportion of Private Specialized Hospitals Continues to Rise
    • 3.1.2. Revenue Generated by Specialized Hospitals Sees Rapid Growth
    • 3.1.3. Specialized Hospitals Differ Dramatically in Profit Margin
  • 3.2. Status Quo of Various Specialized Hospitals
    • 3.2.1. Ophthalmic Hospitals
    • 3.2.2. Dental Hospitals
    • 3.2.3. Plastic Surgery and Cosmetic Hospitals
    • 3.2.4. Obstetrics and Gynecology Hospitals
    • 3.2.5. Children's Hospitals
    • 3.2.6. Tumor Hospitals

4. Development Forecast of China Hospital Industry

  • 4.1. Status Quo of China Medical Insurance
    • 4.1.1. Medical Insurance System
    • 4.1.2. Medical Insurance Nearly Realizes 100% Coverage
    • 4.1.3. Medical Insurance for Serious Illness of Urban and Rural Residents
  • 4.2. Urbanization Bolsters Development of the Hospital Industry
    • 4.2.1. Status Quo of Urbanization in China
    • 4.2.2. Urbanization Expects to Optimize Medical Insurance System
    • 4.2.3. Trans-regional Medical Insurance Settlement is Promoted Soundly
    • 4.2.4. Urbanization Incrementation Depends on the Contribution of Medical Insurance System
    • 4.2.5. Medical Insurance Fund Balance Rate Will See Further Decrease
    • 4.2.6. Medical Resource Supply of County-Level Hospitals Will Improve
    • 4.2.7. Urbanization Will Encourage Central Government to Invest in Urban Medical Resources

5. Investment in China Hospital Industry

  • 5.1. Policy Environment Becomes Warm
  • 5.2. Comparison between Public Hospitals and Private Hospitals
    • 5.2.1. Public Hospitals Occupy a Dominant Position
    • 5.2.2. Private Hospitals See Higher Efficiency of Operation
  • 5.3. Investment Opportunities of Social Capital
    • 5.3.1. Specialized Medical Field
    • 5.3.2. General Public Hospitals
  • 5.4. Development Direction and Operation Mode of Foreign Hospitals
    • 5.4.1. Status Quo of Foreign Hospitals in China
    • 5.4.2. Development Direction of Foreign Hospitals
    • 5.4.3. Operation Mode of Foreign Hospitals

6. Major Chinese Enterprises

  • 6.1. Aier Eye Hospital Group
    • 6.1.1. Profile
    • 6.1.2. Operation
    • 6.1.3. Revenue Structure
    • 6.1.4. Gross Margin
    • 6.1.5. Medical Services
    • 6.1.6. Prediction
  • 6.2. TC Medical
    • 6.2.1. Profile
    • 6.2.2. Operation
    • 6.2.3. Revenue Structure
    • 6.2.4. Gross Margin
    • 6.2.5. Medical Services
    • 6.2.6. Prediction
  • 6.3. Mayinglong Pharm
    • 6.3.1. Profile
    • 6.3.2. Operation
    • 6.3.3. Revenue Structure
    • 6.3.4. Gross Margin
    • 6.3.5. Medical Services
    • 6.3.6. Prediction
  • 6.4. Shanghai Fosun Pharmaceutical
    • 6.4.1. Profile
    • 6.4.2. Operation
    • 6.4.3. Revenue Structure
    • 6.4.4. Gross Margin
    • 6.4.5. R&D and Investment
    • 6.4.6. Medical Services
    • 6.4.7. Prediction
  • 6.5. Jinling Pharmaceutical
    • 6.5.1. Profile
    • 6.5.2. Operation
    • 6.5.3. Revenue Structure
    • 6.5.4. Gross Margin
    • 6.5.5. Medical Services
    • 6.5.6. Prediction
  • 6.6. Shinva Medical
    • 6.6.1. Profile
    • 6.6.2. Operation
    • 6.6.3. Revenue Structure
    • 6.6.4. Gross Margin
    • 6.6.5. Medical Services
    • 6.6.6. Prediction
  • 6.7. Xi'an Kaiyuan Investment
    • 6.7.1. Profile
    • 6.7.2. Operation
    • 6.7.3. Revenue Structure
    • 6.7.4. Gross Margin
    • 6.7.5. Medical Services
    • 6.7.6. Prediction
  • 6.8. Inner Mongolia Furui Medical Science
    • 6.8.1. Profile
    • 6.8.2. Operation
    • 6.8.3. Revenue Structure
    • 6.8.4. Gross Margin
    • 6.8.5. Medical Services
    • 6.8.6. Prediction
  • 6.9. Wuhan Jianmin Pharmaceutical
    • 6.9.1. Profile
    • 6.9.2. Operation
    • 6.9.3. Revenue Structure
    • 6.9.4. Gross Margin
    • 6.9.5. Medical Services
    • 6.9.6. Prediction
  • 6.10. CMS Holdings Ltd.
    • 6.10.1. Profile
    • 6.10.2. Operation
    • 6.10.3. Revenue Structure
    • 6.10.4. Gross Margin
    • 6.10.5. Medical Services
  • 6.11. United Family Hospital
    • 6.11.1. Profile
    • 6.11.2. Operation
    • 6.11.3. Medical Services
  • 6.12. Parkway Pantai
    • 6.12.1. Profile
    • 6.12.2. Operation
    • 6.12.3. Medical Services
  • 6.13. Phoenix Healthcare
    • 6.13.1. Profile
    • 6.13.2. Operation
    • 6.13.3. Medical Services
  • 6.14. Yibai Pharmaceutical
    • 6.14.1. Profile
    • 6.14.2. Operation
    • 6.14.3. Medical Services
  • 6.15. China Resources Sanjiu
    • 6.15.1. Profile
    • 6.15.2. Operation
    • 6.15.3. Medical Services
  • 6.16. Kangmei Pharmaceutical
    • 6.16.1. Profile
    • 6.16.2. Operation
    • 6.16.3. Medical Services
  • 6.17. Jiangnan Mould & Plastic Technology
    • 6.17.1. Profile
    • 6.17.2. Operation
    • 6.17.3. Medical Services

7. Summary and Forecast

  • 7.1. Summary
  • 7.2. Forecast

Selected Charts:

  • Types and Brief Introduction of Hospitals in China
  • China Hospital Industry Chain
  • Number of Hospitals and YoY Growth in China, 2005-2013
  • Number of Hospitals in China by Grade, 2006-2013
  • Number of Hospitals in China by Ownership, 2006-2013
  • Number of Hospitals in China by Management Mode, 2006-2013
  • Number of Hospitals in China by Institution Nature, 2006-2013
  • Number of Hospitals in China by Region, Apr 2014
  • Total Revenue and YoY Growth of China Hospital Industry, 2005-2013
  • Revenue Structure of Chinese Hospitals by Source of Revenue, 2012
  • Revenue Structure of China Hospital Industry by Institution Nature, 2008-2013
  • Average Revenue of China Hospital Industry by Institution Nature, 2008-2013
  • Average Revenue of Each General Hospital in China, 2005-2013
  • Average Revenue of Each General Hospital in China by Business, 2008-2013
  • Makeup Percentage of Drugs of Each General Hospital in China, 2008-2013
  • Profit Margin of Chinese Hospitals, 2006-2013
  • Profit Margin of Chinese Hospitals by Institution Nature, 2009-2013
  • Outpatient Visits of Chinese Hospitals, 2005-2013
  • Number of Hospital Beds and Utilization of Chinese Hospitals, 2005-2013
  • Comparison between Chinese Hospitals, Number of Beds and Utilization by Ownership, 2006-2013
  • Number of Certified Doctors and Registered Nurses of Chinese Hospitals, 2006-2013
  • Number of Chinese Medical Graduates, 2006-2013
  • Proportion of Public and Non-Public Hospitals in Various Medical Fields of China, 2012
  • Number and Proportion of Specialized Hospitals in China, 2006-2013
  • Constitution of Specialized Hospitals in China by Ownership, 2006-2013
  • Number of Specialized Hospitals in China by Classification, 2010-2012
  • Total Revenue and YoY Growth of Specialized Hospitals in China, 2005-2013
  • Total Revenue of Specialized Hospitals in China, 2010-2012
  • Profit Margin of Specialized Hospitals in China, 2010-2012
  • Number of Ophthalmic Hospitals in China, 2006-2012
  • Revenue and Profit of Ophthalmic Hospitals in China, 2006-2012
  • Utilization of Hospital Beds and Service Efficiency of Doctors of Chinese Ophthalmic Hospitals, 2006-2012
  • Number of Chinese Dental Hospitals, 2006-2012
  • Revenue and Profit of Chinese Dental Hospitals, 2006-2012
  • Utilization of Hospital Beds and Service Efficiency of Doctors of Chinese Dental Hospitals, 2006-2012
  • Competition Comparison: TC Medical vs. Jiamei Stomatological vs. ARRAIL Dental
  • Number of Chinese Plastic Surgery and Cosmetic Hospitals, 2006-2012
  • Revenue and Profit of Chinese Plastic Surgery and Cosmetic Hospitals, 2006-2012
  • Number of Chinese Obstetrics and Gynecology Hospitals, 2006-2012
  • Revenue and Profit of Chinese Obstetrics and Gynecology Hospitals, 2006-2012
  • Utilization of Hospital Beds and Service Efficiency of Doctors of Chinese Obstetrics and Gynecology Hospitals, 2006-2012
  • Number of Chinese Children's Hospitals, 2006-2012
  • Revenue and Profit of Chinese Children's Hospitals, 2006-2012
  • Utilization of Hospital Beds and Service Efficiency of Doctors of Chinese Children's Hospitals, 2006-2012
  • Number of Chinese Tumor Hospitals, 2006-2012
  • Revenue and Profit of Chinese Tumor Hospitals, 2006-2012
  • Utilization of Hospital Beds and Service Efficiency of Doctors of Chinese Tumor Hospitals, 2006-2012
  • Composition of China's Medical Insurance System
  • Population Coverage of Medical Insurance System in China, 2005-2013
  • Coverage of China Medical Insurance System, 2005-2013
  • Per Capita Expenditure of Three Kinds of Medical Insurances in China, 2009-2013
  • Urbanization Rate of China, 2000-2013
  • Healthcare Expenditure Structure of China, 2005-2013
  • Basic Insurances of China's Urban Workers and Average Per Capita Fundraising of New Rural Cooperative Medical System, 2007-2013
  • Medical Insurances of China's Urban Workers and Balance Rate of New Rural Cooperative Medical System, 2005-2013
  • Favorable Polices on the Construction of County-Level Hospitals, 2009-2014
  • Influence of In-Depth Urbanization on Medical Service in China, 2015E
  • Landmark Cases on Social Capitals Flowing to Medical Service Field in China, 1985-2014
  • Policies Regarding Social Capitals Flowing to Medical Service Field in China, 2009-2014
  • Policy Differences between Privately-owned Hospitals and Public Hospitals
  • Entrustment Chain of Public Hospitals in China
  • Revenue and Market Share of Chinese Public Hospitals, 2008-2013
  • Profits and Profit Margin of Chinese Public Hospitals, 2008-2013
  • Revenue and Market Share of Chinese Private Hospitals, 2008-2013
  • Profits and Profit Margin of Chinese Private Hospitals, 2008-2013
  • Comparison between Major Specialized Medical Services in China
  • Marketization Trend of China Medical Service System
  • Reform Mode of Existing Property Rights System of Public Hospitals in China
  • Pilot Cases of China's Social Capitals Contributing to Public Hospital Restructuring, 1999-2014
  • Co-partners and Major Medical Services of Some Sino-foreign Cooperative Hospitals in China
  • Co-partners and Major Medical Services of Foreign-led Joint Venture Hospitals in China
  • Revenue, Net Income and Asset-Liability Ratio of Aier Eye Hospital Group, 2009-2014
  • Revenue of Aier Eye Hospital Group by Product, 2009-2013
  • Revenue of Aier Eye Hospital Group by Region, 2009-2013
  • Gross Margin of Aier Eye Hospital Group by Product, 2009-2014
  • Revenue and Net Income of Aier Eye Hospital Group, 2014-2017E
  • Revenue, Net Income and Asset-Liability Ratio of TC Medical, 2009-2014
  • Revenue of TC Medical by Product, 2009-2014
  • Revenue of TC Medical by Region, 2009-2014
  • Gross Margin of TC Medical by Product, 2009-2014
  • Target Clients of TC Medical
  • Operation Comparison between Subsidiaries under TC Medical, 2011 vs 2013
  • Revenue and Net Income of TC Medical, 2014-2017E
  • Revenue, Net Income and Asset-Liability Ratio of Mayinglong Pharm, 2009-2014
  • Revenue of Mayinglong Pharm by Product, 2009-2013
  • Revenue of Mayinglong Pharm by Region, 2009-2013
  • Gross Margin of Mayinglong Pharm by Product, 2009-2014
  • Development History of Anorectum Chain Hospitals under Mayinglong Pharm
  • Establishment Mode and Equity Structure of Anorectum Hospitals under Mayinglong Pharm
  • Diagnosis & Treatment Revenue and YoY Growth of Hospitals under Mayinglong Pharm, 2009-2013
  • Comparison: Anorectum Hospitals under Mayinglong Pharm vs. Aier Eye Hospital Group vs. TC Medical
  • Revenue and Net Income of Mayinglong Pharm, 2014-2017E
  • Revenue, Net Income and Asset-Liability Ratio of Shanghai Fosun Pharmaceutical, 2009-2014
  • Revenue of Shanghai Fosun Pharmaceutical by Product, 2009-2013
  • Revenue of Shanghai Fosun Pharmaceutical by Region, 2009-2013
  • Gross Margin of Shanghai Fosun Pharmaceutical by Product, 2009-2014
  • R&D Costs and % of Total Revenue of Shanghai Fosun Pharmaceutical, 2009-2013
  • Established Regions and Expected Expansion of United Family Hospital, 2014
  • Medical Service Revenue and YoY Growth of Shanghai Fosun Pharmaceutical, 2011-2013
  • Revenue and Net Income of Shanghai Fosun Pharmaceutical, 2014-2017E
  • Revenue, Net Income and Asset-Liability Ratio of Jinling Pharmaceutical , 2009-2014
  • Revenue of Jinling Pharmaceutical by Product, 2009-2013
  • Revenue of Jinling Pharmaceutical by Region, 2009-2013
  • Gross Margin of Jinling Pharmaceutical by Product, 2009-2014
  • Medical Revenue and YoY Growth of Jinling Pharmaceutical, 2009-2013
  • Revenue and Net Income of Jinling Pharmaceutical, 2014-2017E
  • Revenue, Net Income and Asset-Liability Ratio of Shinva Medical, 2009-2014
  • Revenue of Shinva Medical by Product, 2009-2013
  • Revenue of Shinva Medical by Region, 2009-2013
  • Gross Margin of Shinva Medical by Product, 2009-2014
  • Revenue and Net Income of Shinva Medical, 2014-2017E
  • Revenue, Net Income and Asset-Liability Ratio of Xi'an Kaiyuan Investment, 2009-2014
  • Revenue of Xi'an Kaiyuan Investment by Sector, 2009-2013
  • Revenue of Xi'an Kaiyuan Investment by Region, 2009-2013
  • Gross Margin of Xi'an Kaiyuan Investment by Product, 2009-2014
  • Medical Revenue of Xi'an Kaiyuan Investment, 2011-2013
  • Revenue, Net Income and Net Profit Margin of Xi'an Gaoxin Hospitals, 2011-2013
  • Revenue and Net Income of Xi'an Kaiyuan Investment, 2014-2017E
  • Revenue, Net Income and Asset-Liability Ratio of Inner Mongolia Furui Medical Science, 2009-2014
  • Revenue of Inner Mongolia Furui Medical Science by Product, 2009-2013
  • Revenue of Inner Mongolia Furui Medical Science by Region, 2009-2013
  • Gross Margin of Inner Mongolia Furui Medical Science by Product, 2009-2014
  • Investment and Operating Time of Chain Hospitals under Inner Mongolia Furui Medical Science
  • Revenue and Net Income of Inner Mongolia Furui Medical Science, 2014-2017E
  • Revenue, Net Income and Asset-Liability Ratio of Wuhan Jianmin Pharmaceutical, 2009-2014
  • Revenue and Net Income of Wuhan Jianmin Pharmaceutical, 2009-2014
  • Revenue of Wuhan Jianmin Pharmaceutical by Product, 2009-2013
  • Revenue of Wuhan Jianmin Pharmaceutical by Region, 2009-2013
  • Gross Margin of Wuhan Jianmin Pharmaceutical by Product, 2009-2014
  • Revenue and Net Income of Wuhan Jianmin Pharmaceutical, 2014-2017E
  • Revenue and Net Income of CMS, 2009-2014
  • Revenue of CMS by Product, 2011-2013
  • Gross Margin of CMS by Product, 2009-2014
  • Service Network Coverage Regions of CMS
  • Revenue and Proportion of Hospitals of CMS, 2012-2013
  • Revenue and YoY Growth of United Family Hospital, 2007-2013
  • Number of United Family Hospital's Outlets by Region, 2014
  • Revenue, Net Income and Net Profit Margin of Parkway Pantai, FY2011-2014
  • Revenue of IHH Healthcare and YoY Growth in China, FY2011-2013
  • Medical Treatment Centers and Services of Parkway Pantai in China
  • Revenue, Net Income and Asset-Liability Ratio of Phoenix Healthcare, 2010-2013
  • Service Revenue and YoY Growth of General Hospitals under Phoenix Healthcare, 2010-2013
  • Hospital Management Revenue Structure (by Hospital) of Phoenix Healthcare, 2013
  • Revenue, Net Income and Asset-Liability Ratio of Yibai Pharmaceutical, 2009-2014
  • Medical Service Revenue and YoY Growth of Yibai Pharmaceutical, 2009-2013
  • Revenue, Net Income and Asset-Liability Ratio of China Resources Sanjiu, 2009-2014
  • Medical Service Revenue and YoY Growth of China Resources Sanjiu, 2009-2013
  • Revenue, Net Income and Asset-Liability Ratio of Kangmei Pharmaceutical, 2009-2014
  • Revenue, Net Income and Asset-Liability Ratio of Jiangnan Mould & Plastic Technology, 2009-2014
  • Medical Service Revenue of Chinese Hospitals (by Enterprise), 2011-2017E
  • Number and YoY Growth of Chinese Hospitals, 2010-2017E
  • Total Revenue and YoY Growth of Chinese Hospital Industry, 2010-2017E
  • Total Revenue of Chinese Hospital Industry by Ownership, 2010-2017E
  • Number and Proportion of Chinese Specialized Hospitals, 2010-2017E
  • Total Revenue and YoY Growth of Chinese Specialized Hospitals, 2010-2017E
Back to Top